Literature DB >> 17198852

Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

Jie Jin Wang1, Elena Rochtchina, Anne J Lee, Ee-Munn Chia, Wayne Smith, Robert G Cumming, Paul Mitchell.   

Abstract

PURPOSE: To assess the 10-year incidence of age-related maculopathy (ARM) in an older Australian cohort.
DESIGN: Population-based cohort study. PARTICIPANTS: Three thousand six hundred fifty-four Blue Mountains Eye Study participants > or =49 years old were examined during 1992 through 1994; 2335 (75% of survivors) were reexamined after 5 years (1997-1999) and 1952 (76% of survivors) after 10 years (2002-2004).
METHODS: The same graders performed retinal photographic grading in all examinations, using the Wisconsin Age-Related Maculopathy Grading System. Photographs of participants with ARM lesions at any of the examinations were subsequently regraded using a side-by-side comparison method. MAIN OUTCOME MEASURES: The diagnosis of incident late ARM was given if neovascular ARM or geographic atrophy was detected at either follow-up examination in persons free of these lesions at baseline. Incident early ARM was diagnosed if early ARM (soft indistinct or reticular drusen or combined soft distinct drusen and retinal pigment abnormality) was present in persons free of early and late ARM at baseline. Age-related maculopathy incidence was calculated using Kaplan-Meier methods to incorporate information from both 5- and 10-year examinations. Discrete logistic models were used to assess the risk of incident late ARM according to various baseline factors, including early ARM lesion characteristics.
RESULTS: After excluding 72 late ARM cases present at baseline, 2395 of 3582 subjects at risk of late ARM (67%) were reexamined at either follow-up time point or both follow-up time points. Over the 10-year period, 72 of 2395 subjects (3.7%) developed late ARM and 266 of 2255 subjects (14.1%) developed early ARM. After age standardization to the Beaver Dam Eye Study population, our 10-year incidences of late and early ARM were 2.8% and 10.8%, respectively. Baseline age and early ARM lesion characteristics and severity were strong predictors of late ARM incidence.
CONCLUSIONS: Long-term follow-up of this older population confirms that the risk of ARM progression is related strongly to the severity of early-stage lesions. The study provides evidence-based criteria for identifying persons at high risk of developing late ARM.

Entities:  

Mesh:

Year:  2007        PMID: 17198852     DOI: 10.1016/j.ophtha.2006.07.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  84 in total

1.  [Forms of age-related macular degeneration].

Authors:  M Schargus
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

2.  Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy.

Authors:  Martin Rudolf; Mark E Clark; Melissa F Chimento; Chuan-Ming Li; Nancy E Medeiros; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

3.  [Reticular drusen over time with SD-OCT].

Authors:  J Auge; J S Steinberg; M Fleckenstein; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

4.  Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.

Authors:  G Silvestri; M A Williams; C McAuley; K Oakes; E Sillery; D C Henderson; S Ferguson; V Silvestri; K A Muldrew
Journal:  Eye (Lond)       Date:  2012-08-17       Impact factor: 3.775

5.  A risk score for the prediction of advanced age-related macular degeneration: development and validation in 2 prospective cohorts.

Authors:  Chung-Jung Chiu; Paul Mitchell; Ronald Klein; Barbara E Klein; Min-Lee Chang; Gary Gensler; Allen Taylor
Journal:  Ophthalmology       Date:  2014-03-18       Impact factor: 12.079

6.  A false color fusion strategy for drusen and geographic atrophy visualization in optical coherence tomography images.

Authors:  Qiang Chen; Theodore Leng; Sijie Niu; Jiajia Shi; Luis de Sisternes; Daniel L Rubin
Journal:  Retina       Date:  2014-12       Impact factor: 4.256

7.  Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.

Authors:  Fridbert Jonasson; Diana E Fisher; Gudny Eiriksdottir; Sigurdur Sigurdsson; Ronald Klein; Lenore J Launer; Tamara Harris; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2014-04-24       Impact factor: 12.079

8.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

9.  Understanding the patient's lived experience of neovascular age-related macular degeneration: a qualitative study.

Authors:  C McCloud; S Lake
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

10.  Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.

Authors:  Ronald Klein; Stacy M Meuer; Chelsea E Myers; Gabriëlle H S Buitendijk; Elena Rochtchina; Farzana Choudhury; Paulus T V M de Jong; Roberta McKean-Cowdin; Sudha K Iyengar; Xiaoyi Gao; Kristine E Lee; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Jie Jin Wang; Barbara E K Klein
Journal:  Ophthalmic Epidemiol       Date:  2014-02       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.